Cargando…
Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach—A Real World Data Analysis
SIMPLE SUMMARY: Molecular tumor signatures are becoming increasingly important in the treatment of metastatic adenocarcinomas of the gastroesophageal junction (GEJ) and stomach (GC). There are few studies available analyzing data from the Caucasian population regarding molecular signatures and bioma...
Autores principales: | Hempel, Louisa, de Oliveira, Julia Veloso, Gaumann, Andreas, Milani, Valeria, Schweneker, Katrin, Schenck, Kristina, Fleischmann, Bastian, Philipp, Patrick, Mederle, Stefanie, Garg, Arun, Piehler, Armin, Gandorfer, Beate, Schick, Cordula, Kleespies, Axel, Sellmann, Ludger, Bartels, Marius, Goetze, Thorsten Oliver, Stein, Alexander, Goekkurt, Eray, Pfitzner, Lucia, Robert, Sebastian, Hempel, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431038/ https://www.ncbi.nlm.nih.gov/pubmed/34503263 http://dx.doi.org/10.3390/cancers13174453 |
Ejemplares similares
-
Rare SARS-CoV-2 antibody development in cancer patients
por: Hempel, Louisa, et al.
Publicado: (2021) -
SARS‐CoV‐2 infections in cancer outpatients—Most infected patients are asymptomatic carriers without impact on chemotherapy
por: Hempel, Louisa, et al.
Publicado: (2020) -
Responses of patients with cancer to mRNA vaccines depend on the time interval between vaccination and last treatment
por: Donhauser, Lara Victoria, et al.
Publicado: (2023) -
1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy
por: Hempel, D., et al.
Publicado: (2020) -
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma
por: Sun, Weijing, et al.
Publicado: (2023)